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multiple testing in statistical analysis was done using the 
Benjamini-Hochberg method. 
 
Results: With a median follow up of 34 months, the 3-year 
LC, PFS and OS (with 95% confidence intervals) were 64% (53% 
- 75%), 51% (39% - 62%) and 77% (67% - 87%), respectively. No 
image features were significantly correlated with LC or PFS 
and adding image features to the clinical variables did not 
improve the performance of the Cox model in the bCV 
setting, as seen in Table 1 where the C-index is highlighted in 




MTV was the image feature most closely related to OS and for 
OS the addition of image features did improve the predictive 
performance of the Cox model. Figure 1 shows the effect of 
dividing the patient population based on the statistically 
most important variables, where it is clear that Karnofsky 




Adding image features to complement clinical parameters 
was seen to improve the prognostic value for OS. Although no 
significant image features were found related to LC and PFS, 
we found that a smaller MTV was predictive of improved OS. 
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Purpose or Objective: Among cancers of head and neck, 
hypopharyngeal cancers tend to have an aggressive clinical 
course. Chemoradiation has become the standard of care for 
patients who are candidates for an organ preservation 
strategy. IMRT planning has incorporated a simultaneous 
integrated boost (SIB-IMRT) in order to efficiently develop 
comprehensive radiation therapy plans and also potentially 
lessen treatment time and toxicity. Outcomes and toxicites 
of patients with hypopharyngeal cancers treated in a single 
institute with standard IMRT and SIB-IMRT schedules were 
analyzed retrospectively. 
 
Material and Methods: A total of 86 patients with 
hypopharyngeal squamous cell carcinomas were treated 
between September 2010 and December 2014. Among 44 
patients who were treated using SIB-IMRT, 8 received 
neoadjuvant chemotherapy (NACT) and 42 received 
concurrent chemotherapy. Among 42 patients who were 
treated using IMRT with conventional fractionation (IMRT),16 
received NACT and 40 received concurrent chemotherapy. 
The dose for SIB-IMRT group was 65 Gy in 30 fractions to gross 
and high risk disease and 54 Gy in 30 fractions to low-risk 
nodes. The dose in IMRT group was 66-70 Gy to gross disease, 
60 Gy to high risk nodes and 50 Gy to low risk nodes in 1.8-2 
Gy per fraction. 
 
Results: At a median follow-up of 16.5 months (6-56 months) 
the median OS of entire cohort was 38.9 months. The mean 
OS was 37.5 months and 38.3 months (p=0.91) for SIB-IMRT 
and IMRT respectively. The mean treatment duration for SIB-
IMRT and IMRT groups was 42 days (range: 38-51 days) and 
48.4 days (range: 45-73 days) respectively. 98 % in SIB-IMRT 
and 93 % patients in IMRT group completed the intended 
treatment. Complete response was noted in 89 % and 93 % in 
SIB-IMRT and IMRT groups respectively. The estimated 1 year, 
2 year LR control and 2-year DFS were 81%, 66.6%, 67.4% in 
SIB-IMRT and 84%, 74%, 62% (p<0.81) in IMRT groups 
respectively.Grade 3 mucositis occurred in 10 (23%) and 12 
(28%), grade 3 dermatitis in 9 (20.5%) and 12 (28%) of SIB-
IMRT and IMRT patients respectively. Grade 2 xerostomia 
occurred in 11 patients (27%) and 15 patients (34%) in IMRT 
and SIB-IMRT groups. Grade 3 soft-tissue fibrosis and 
esophageal stricture rates were 2 (4.7 %) and 5 (11.4%) in SIB-




Conclusion: Clinical outcomes, acute and late toxicities of 
chemo-radiation with SIB-IMRT were comparable with IMRT. 
Overall treatment duration was reduced and more patients 
completed intended treatment in SIB-IMRT group with 
relatively lesser acute toxicities. 
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Purpose or Objective: Radiation Therapy Oncology Group 
(RTOG) guidelines recommend brachial plexus dose 
constraints ranging from 60-66Gy in 2Gy per fraction (BED = 
120-132Gy2). However there remains limited data on brachial 
plexus (BR.P) toxicity and furthermore the dose limits are 
